Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-11

Clinical Trial Update: Clinical Efficacy and sAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary Intervention [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the efficacy and safety of intravenous nicorandil during primary percutaneous coronary intervention for ST-elevation myocardial infarcti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicorandil (nicorandil)

Snippet

Sponsor: Fudan University | Conditions: ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention | Phase 4 | Status: COMPLETED